Drug Patents owned by Cardinal Health 414

1. Drug name - LYMPHOSEEK KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6409990 CARDINAL HEALTH 414 Macromolecular carrier for drug and diagnostic agent delivery
May, 2025

(2 years from now)

US9439985 CARDINAL HEALTH 414 Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran
Sep, 2033

(10 years from now)

CN102301429A CARDINAL HEALTH 414 Diethylenetriaminepentaacetic Acid (Dtpa)-Sephadex Gel For Radioactive Mark
Aug, 2014

(8 years ago)

EP1178838B1 CARDINAL HEALTH 414 Macromolecular Carrier Based On Dextran For Drug And Diagnostic Agent Delivery
May, 2020

(2 years ago)

EP1178838A2 CARDINAL HEALTH 414 Macromolecular Carrier Based On Dextran For Drug And Diagnostic Agent Delivery
May, 2020

(2 years ago)

EP2392012A1 CARDINAL HEALTH 414 Compositions For Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Jan, 2030

(7 years from now)

EP2392012B1 CARDINAL HEALTH 414 Compositions For Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Jan, 2030

(7 years from now)

EP2392012A4 CARDINAL HEALTH 414 Compositions For Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Jan, 2030

(7 years from now)

More Information on Dosage
Strength Dosage Availability
N/A INJECTABLE;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.